A0A1L7NY50 (A0A1L7NY50_HUMAN) Homo sapiens (Human)

Polypeptide N-acetylgalactosaminyltransferase UniProtKBInterProInteractive Modelling

571 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q10471

Available Structures

13 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
GalNAc-T2 crystal soaked with UDP-5SGalNAc, mEA2 peptide and manganese (Lower resolution dataset) Heteromer
Q10471; Q6FI18;
75-570
MN;BBK;UDP;
Assess
Crystal structure of the inactive form of GalNAc-T2 in complex with the glycopeptide MUC5AC-3,13 Heteromer
P98088; Q10471;
75-569
A2G; 31×SO4;
Assess
Crystal structure of the active form of GalNAc-T2 in complex with UDP and the glycopeptide MUC5AC-13 Heteromer
P98088; Q10471;
75-569
UDP; 21×SO4;MN;A2G;
Assess
Crystal structure of the inactive form of GalNAc-T2 in complex with the glycopeptide MUC5AC-Cys13 Heteromer
P98088; Q10471;
75-569
12×SO4; 14×EDO;A2G;
Assess
GalNAc-T2 crystal soaked with UDP-5SGalNAc, mEA2 and manganese (Higher resolution dataset) Heteromer
Q10471; Q6FI18;
75-569
MN;HWU;EDO;BBK;
Assess
Crystal Structure of Human ppGalNAcT-2 complexed with UDP and EA2 Heteromer
Q10471; Q63549;
75-568
MN;UDP;
Assess
Human ppGalNAcT2 I253A/L310A Mutant with EA2 and UDP Heteromer
Q10471; Q62605;
75-568
UDP;MN;
Assess
Crystal structure of GalNAc-T2 in complex with compound 16dhomo-2-mer75-569
UDP;MN;EDO;GOL;
Assess
Small-molecule inhibition of ppGalNAc-Ts selectively reduces mucin-type O-glycosylationhomo-2-mer75-569
MN;UDP;EDO;
Assess
GalNAc-T2 crystal soaked with UDP-GalNAc, EA2 peptide and manganesehomo-2-mer75-569
MN;UDP;EDO;UD2;NGA;
Assess
GalNac-T2 soaked with UDP-sugarhomo-2-mer75-569
MN;LR7;
Assess
Crystal structure of the GalNAc-T2 F104S mutant in complex with UDP-GalNAcmonomer75-570
MN;UD2;
Assess
Human ppGalNAcT-2 complexed with manganese and UDPmonomer75-570
MN;UDP;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5fv9.1.Ahomo-2-mer0.8575-569
UDP;MN;99.82
Assess